{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T19:40:15Z","timestamp":1710013215500},"reference-count":22,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":9435,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1989,11]]},"DOI":"10.1111\/j.1600-0404.1989.tb03899.x","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T19:45:46Z","timestamp":1233258346000},"page":"390-393","source":"Crossref","is-referenced-by-count":10,"title":["Interleukin 1 and 2 production by peripheral blood mononuclear cells in subacute sclerosing panencephalitis and exacerbation of multiple sclerosis"],"prefix":"10.1155","volume":"80","author":[{"given":"W.","family":"Brajczewska-Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Iwi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kruszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Korlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Czlonkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00918247","article-title":"An update on human interleukin-1: from molecular biology to clinical relevance","volume":"5","author":"Dinarello","year":"1985","journal-title":"J Clin Immunol"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB2","first-page":"45","article-title":"Recent advances in the understanding of the biochemistry and clinical pharmacology of interleukin 2","volume":"6","author":"Fletcher","year":"1987","journal-title":"Lymphokine Res"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3181\/00379727-175-41798","article-title":"Multiple sclerosis as a disease of immune regulation","volume":"175","author":"Waksman","year":"1984","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1212\/WNL.28.10.999","article-title":"Mitogen responsiveness and suppressor cell function in multiple sclerosis","volume":"28","author":"Antel","year":"1978","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB5","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/WNL.36.7.992","article-title":"Subacute sclerosing panencephalitis and progressive multiple sclerosis: T cell subsets in blood and CSF","volume":"36","author":"Czlonkowska","year":"1986","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB6","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1001\/jama.1969.03150250078007","article-title":"Subacute sclerosing panencephalitis: a multi-disciplinary study of eight cases","volume":"207","author":"Jabbour","year":"1969","journal-title":"JAMA"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB7","first-page":"22","article-title":"Production of intra- and extracellular interleukin 1 by human monocytes","volume":"34","author":"Lepe-Zuniga","year":"1984","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB8","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.4049\/jimmunol.120.6.2027","article-title":"T cell growth factor: parameters of production and a quantitative microassay for activity","volume":"120","author":"Gills","year":"1978","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB9","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/JCM.25.9.1695-1700.1987","article-title":"Idiopathic production of interleukin-1 in acquired immune deficiency syndrome","volume":"25","author":"Lepe-Zuniga","year":"1987","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB10","first-page":"648","article-title":"Cerebrospinal fluid interleukin 1-like activity during chronic relapsing experimental allergic encephalomyelitis","volume":"68","author":"Symons","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000157039","article-title":"Biologic activities of interleukin-1 relevant to rheumatic disease","volume":"6","author":"Miller","year":"1987","journal-title":"Pathol Immunopathol Res"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB12","first-page":"556","article-title":"In vitro correction of the interleukin 2 and interferon-gamma defect in multiple sclerosis","volume":"61","author":"Vervliet","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1600-0404.1983.tb04576.x","article-title":"Subacute sclerosing panencephalitis: influence of the clinical course and treatment with isoprinosine in non-specific cell-mediated and humoral immunity","volume":"67","author":"Vainiene","year":"1983","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB14","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.4049\/jimmunol.133.4.1931","article-title":"Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis","volume":"133","author":"Merrill","year":"1984","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB15","first-page":"248","article-title":"The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes","volume":"61","author":"Bellamy","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB16","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1212\/WNL.36.10.1392","article-title":"Multiple sclerosis increases expression of interleukin-2 receptors on lymphocytes","volume":"36","author":"Selmaj","year":"1986","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB17","first-page":"303","article-title":"Expression du recepteur de l'inrerleukine 2 et des antigenes d'histocompatibilite de clase II sue les lymphocytes du liquide cephalorachidien chez des patients atteints de sclerose en plaques et d'autres maladies neurologiques","volume":"35","author":"Tournier-Lasserve","year":"1987","journal-title":"Pathol Biol (Paris)"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0022-510X(88)90036-6","article-title":"Interleukin-1 and interleukin-2 production by peripheral blood mononuclear cells in multiple sclerosis","volume":"85","author":"Selmaj","year":"1988","journal-title":"J Neurol Sci"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB19","first-page":"223","article-title":"Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases","volume":"4","author":"Merrill","year":"1983","journal-title":"I. Associated between amount of prostaglandin produced, natural killer, and endogenous interferon. J Neuroimmunol"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB20","first-page":"239","article-title":"Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases","volume":"4","author":"Merrill","year":"1983","journal-title":"II. Effect of exogenous PGE on spontaneous and interferon-induced natural killer. J Neuroimmunol"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB21","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.4049\/jimmunol.130.4.1770","article-title":"Lymphokine regulation of activatated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition on interleukin 2 production","volume":"130","author":"Walker","year":"1983","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-0404.1989.tb03899.x-BIB22","first-page":"286","article-title":"Assessment of the results of treatment of patients with SSPE with preparation TFX Polfa","volume":"19","author":"Vainiene","year":"1985","journal-title":"Neurol Neurochir Pol"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.1989.tb03899.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.1989.tb03899.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T19:27:35Z","timestamp":1710012455000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.1989.tb03899.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,11]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1989,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.1989.tb03899.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"value":"0001-6314","type":"print"},{"value":"1600-0404","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,11]]}}}